Could the differences in the biochemistry of prostate carcinoma compared to benign prostate tissue biopsy fragments be evaluated through Raman spectroscopy?

Landulfo Silveira Jr.; Kátia Ramos M. Leite M.D.; Miguel Srougi M.D.; Fabrício L. Silveira; Marcos Tadeu T. Pacheco; Renato A. Zângaro; Carlos A. Pasqualucci M.D.

doi:10.1117/12.2005412

8 March 2013 Could the differences in the biochemistry of prostate carcinoma compared to benign prostate tissue biopsy fragments be evaluated through Raman spectroscopy?

Landulfo Silveira Jr., Kátia Ramos M. Leite M.D., Miguel Srougi M.D., Fabrício L. Silveira, Marcos Tadeu T. Pacheco, Renato A. Zângaro, Carlos A. Pasqualucci M.D.

Author Affiliations +

Proceedings Volume 8565, Photonic Therapeutics and Diagnostics IX; 85651I (2013) https://doi.org/10.1117/12.2005412
Event: SPIE BiOS, 2013, San Francisco, California, United States

Abstract

It has been proposed a spectral model to evaluate the biochemical differences between prostate carcinoma and benign fragments using dispersive Raman spectroscopy. We have examined 51 prostate fragments from surgically removed PrCa; each fragment was snap-frozen and stored (-80°C) prior spectral analysis. Raman spectrum was measured using a Raman spectrometer (830 nm excitation) coupled to a fiber-optic probe. Integration time and laser power were set to 50 s and 300 mW, respectively. It has been collected triplicate spectra from each fragment (total 153 spectra). Some samples exhibited a strong fluorescence, which was removed by a 7th order polynomial fitting. It has been developed a spectral model based on the least-squares fitting of the spectra of pure biochemicals (actin, collagen, elastin, carotene, glycogen, phosphatidylcholine, hemoglobin, and water) with the spectra of tissues, where the fitting parameters are the relative contribution of the compounds to the tissue spectrum. The spectra (600-1800 cm^-1 range) are dominated by bands of proteins; it has been found a small difference in the mean spectra of PrCa compared to the benign tissue, mainly in the 1000-1400 cm^-1 region, indicating similar biochemical constitution. The spectral fitting model revealed that elastin and phosphatidylcholine were increased in PrCa, whereas blood and water were reduced in malignant lesions (p < 0.05). A discrimination of PrCa from benign tissue using Mahalanobis distance applied to the contribution of elastin, hemoglobin and phosphatidylcholine resulted in sensitivity of 72% and specificity of 70%.

Citation Download Citation

Landulfo Silveira Jr., Kátia Ramos M. Leite M.D., Miguel Srougi M.D., Fabrício L. Silveira, Marcos Tadeu T. Pacheco, Renato A. Zângaro, and Carlos A. Pasqualucci M.D. "Could the differences in the biochemistry of prostate carcinoma compared to benign prostate tissue biopsy fragments be evaluated through Raman spectroscopy?", Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 85651I (8 March 2013); https://doi.org/10.1117/12.2005412

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
7 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Raman spectroscopy

Tissues

Prostate

Tumor growth modeling

Tissue optics

Blood

Proteins

Show All Keywords

Keywords/Phrases

Search In:

Publication Years